Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Velsecorat (AZD7594) in Mild to Moderate Asthma
NCT02479412Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2015
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of velsecorat in asthma, sponsored by AstraZeneca. Started Jun 2015; status: completed.
02
Drugs
velsecorat
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02479412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479412.